Fig. 5
From: The effects of the gut bacterial product, gassericin A, on obesity in mice
Impacts of gassericin A on the genes associated with obesity. The control (C) group received placebo while the GA group (n = 10, each) received gassericin A (3 mIU/kg, i.p.) daily for 10 weeks. The gene expression levels in mesenteric fat are reported as medians and quartiles. *P < 0.05, **P < 0.01